Initial report of a family registry of multiple myeloma

Cancer Nursing

Volumn 32, Issue 6, 2009, Pages 456-464

  Coleman, Elizabeth Ann ^a   Lynch, Henry ^b   Enderlin, Carol ^a   Stewart, Beth ^a   Thomé, Stephan D ^b   Kennedy, Robert ^a   Richardson Nelson, Tami ^b   Barlogie, Bart ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Factors; Familial risk; Genetic and environmental; Multiple myeloma

Indexed keywords

HERBICIDE; INSECTICIDE; PESTICIDE;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BREAST CANCER; CANCER PATIENT; CATTLE; COTTON; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOLECULAR EPIDEMIOLOGY; MULTIPLE MYELOMA; PANCREAS CANCER; PEDIGREE; PRIORITY JOURNAL; REGISTER; RURAL AREA; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PEDIGREE; PHENOTYPE; REGISTRIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; UNITED STATES;

EID: 73649085170     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/NCC.0b013e3181a90168     Document Type: Article

References (42)

1. Cancer Facts and Figures 2008. http://www.cancer.org/downloads/STT/ 2008CAFFfinalsecured.pdf. Accessed January 21, 2009.
2. SEER Cancer Statistics Review, 1975-2002 (based on November 2004 SEER data submission). http://seer.cancer.gov/csr/1975-2002/. Accessed January 21, 2009.
3. Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood. 1998;91(1):3-21.
4. Desikan R, Barlogie B, Sawyer J, et al. Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood. 2000;95(12):4008-4010.
5. Cao J, Hong CH, Rosen L, et al. Deletion of genetic material from a poly(ADP-ribose) polymerase-like gene on chromosome 13 occurs frequently in patients with monoclonal gammopathies. Cancer Epidemiol Biomarkers Prev. 1995;4(7):759-763.
6. Cherney BW, McBride OW, Chen DF, et al. cDNA sequence, protein structure, and chromosomal location of the human gene for poly(ADPribose) polymerase. Proc Natl Acad Sci U S A. 1987;84(23):8370-8374.
7. Alkhatib HM, Chen DF, Cherney B, et al. Cloning and expression of cDNA for human poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A. 1987;84(5):1224-1228.
8. Dilworth D, Liu L, Stewart AK, Berenson JR, Lassam N, Hogg D. Germline CDKN2A mutation implicated in predisposition to multiple myeloma. Blood. 2000;95(5):1869-1871.
9. Zheng C, Huang D, Liu L, et al. Interleukin-10 gene promoter polymorphisms in multiple myeloma. Int J Cancer. 2001;95(3):184-188.
10. Annunziata CM, Davis RE, Demchenko Y, et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007;12(2):115-130.
11. Keats JJ, Fonseca R, Chesi M, et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell. 2007; 12(2):131-144.
12. Shoenfeld Y, Berliner S, Shaklai M,Gallant LA, Pinkhas J. Familial multiple myeloma. A review of thirty-seven families. Postgrad Med J. 1982; 58(675):12-16.
13. Meijers KA, De Leeu MB, Voormolen-Kalova M. The multiple occurrence of myeloma and asymptomatic paraproteinaemia within one family. Clin Exp Immunol. 1972;12(2):185-193.
14. Lynch HT, Sanger WG, Pirruccello S, Quinn-Laquer B, Weisenburger DD. Familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst. 2001;93(19):1479-1483.
15. Loth TS, Perrotta AL, Lima J, Whiteaker RS, Robinson A. Genetic aspects of familial multiple myeloma. Mil Med. 1991;156(8):430-433.
16. Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based casecontrol study. Int J Cancer. 2006;118(12):3095-3098.
17. Hemminki K. Re: familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst. 2002;94(6):462-463; author reply 463.
18. Grosbois B, Jego P, Attal M, et al. Familial multiple myeloma: report of fifteen families. Br J Haematol. 1999;105(3):768-770.
19. Eriksson M, Hallberg B. Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study. Cancer Causes Control. 1992;3(1):63-67.
20. Brown LM, Linet MS, Greenberg RS, et al. Multiple myeloma and family history of cancer among blacks and whites in the U.S. Cancer. 1999;85(11): 2385-2390.
21. Lynch HT, Watson P, Tarantolo S, et al. Phenotypic heterogeneity in multiple myeloma families. J Clin Oncol. 2005;23(4):685-693.
22. Sobol H, Vey N, Sauvan R, Philip N, Noguchi T, Eisinger F. Re: familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst. 2002;94(6):461-462; author reply 463.
23. Jain M, Ascensao J, Schechter GP. Familial myeloma and monoclonal gammopathy: a report of eight African American families. Am J Hematol. 2009;84(1):34-38.
24. Fonseca R, Barlogie B, Bataille R, et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res. 2004;64(4): 1546-1558.
25. Ashcraft PF, Coleman EA, Lange U, Enderlin C, Stewart CB. Obtaining family histories from patients with cancer. Clin J Oncol Nurs. 2007;11(1): 119-124.
26. Orsi L, Troussard X, Monnereau A, et al. Occupation and lymphoid malignancies: results from a French case-control study. J Occup Environ Med. 2007;49(12):1339-1350.
27. Statistics. http://www.traveliowa.com/iowafacts/statistics.html. Accessed September 29, 2008.
28. Huebner WW, Wojcik NC, Rosamilia K, Jorgensen G, Milano CA. Mortality updates (1970Y1997) of two refinery/petrochemical plant cohorts at Baton Rouge, Louisiana, and Baytown, Texas. J Occup Environ Med. 2004;46(12):1229-1245.
29. Raaschou-Nielsen O, Hansen J, McLaughlin JK, et al. Cancer risk among workers at Danish companies using trichloroethylene: a cohort study. Am J Epidemiol. 2003;158(12):1182-1192.
30. Coggon D, Harris EC, Poole J, Palmer KT. Extended follow-up of a cohort of British chemical workers exposed to formaldehyde. J Natl Cancer Inst. 2003;95(21):1608-1615.
31. Rinsky RA, Hornung RW, Silver SR, Tseng CY. Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment. Am J Ind Med. 2002;42(6):474-480.
32. Kirkeleit J, Riise T, BratveitM,Moen BE. Increased risk of acute myelogenous leukemia and multiple myeloma in a historical cohort of upstream petroleum workers exposed to crude oil. Cancer Causes Control. 2008;19(1):13-23.
33. Lincz LF, Scorgie FE, Robertson R, Enno A. Genetic variations in benzene metabolism and susceptibility to multiple myeloma. Leuk Res. 2007;31(6): 759-763.
34. Speer SA, Semenza JC, Kurosaki T, Anton-Culver H. Risk factors for acute myeloid leukemia and multiple myeloma: a combination of GIS and case-control studies. J Environ Health. 2002;64(7):9-16; quiz 35-16.
35. Nieters A, Deeg E, Becker N. Tobacco and alcohol consumption and risk of lymphoma: results of a population-based case-control study in Germany. Int J Cancer. 2006;118(2):422-430.
36. Fernberg P, Odenbro A, Bellocco R, et al. Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden. Cancer Res. 2007;67(12):5983-5986.
37. Brown LM, Gridley G, Check D, Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood. 2008;111(7):3388-3394.
38. McGlynn KA, Gridley G, Mellemkjaer L, et al. Risks of cancer among a cohort of 23,935 men and women with osteoporosis. Int J Cancer. 2008; 122(8):1879-1884.
39. Atkinson WD, Law DV, Bromley KJ, Inskip HM. Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1997. Occup Environ Med. 2004;61(7):577-585.
40. Linet MS, Freedman DM, Mohan AK, et al. Incidence of haematopoietic malignancies in US radiologic technologists. Occup Environ Med. 2005;62(12):861-867.
41. Hatcher JL, Baris D, Olshan AF, et al. Diagnostic radiation and the risk of multiple myeloma (United States). Cancer Causes Control. 2001;12(8): 755-761.
42. Camp NJ, Werner TL, Cannon-Albright LA. Familial myeloma. N Engl J Med. 2008;359(16):1734-1735; author reply 1735.